The FDA released a new guidance titled “Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act (DSCSA) During the COVID-19 Public Health Emergency” on April 30, 2020.
Innovative Strategies for Ensuring Brand Protection
This study explains how the Excellis health check and brand risk assessment can help pharma firms minimize security challenges, and is available to download now.